查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1953443

藥物檢測市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、樣本、藥物類型、最終用戶、地區和競爭格局分類，2021-2031年）

Drug Testing Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Sample, By Drug Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球藥物檢測市場預計將從 2025 年的 155.6 億美元成長到 2031 年的 212.6 億美元，複合年成長率為 5.34%。

該行業利用技術檢體尿液、毛髮、口腔液和血液等生物樣本，以識別非法藥物或其代謝物。推動該行業成長的關鍵因素包括政府對職場安全的嚴格監管以及全球藥物濫用問題的日益嚴重，這些因素都要求進行嚴格的篩檢以最大程度地降低職業風險。根據美國國家安全委員會2024年的數據，78%的受訪雇主對職場鴉片類藥物使用的影響表示擔憂，這凸顯了製定有效篩檢方案以確保工作安全和降低責任風險的緊迫性。

市場概覽
預測期 2027-2031
市場規模：2025年 155.6億美元
市場規模：2031年 212.6億美元
複合年成長率：2026-2031年 5.34%
成長最快的細分市場 尿液樣本
最大的市場 北美洲

然而，由於隱私權和先前受管制物質（尤其是大麻）合法化方面的複雜監管環境，市場擴張面臨許多障礙。不同司法管轄區的法律差異給跨國公司帶來了沉重的合規負擔，迫使它們限制檢測通訊協定的範圍。這種法律碎片化阻礙了標準化全球檢測政策的實施，並限制了某些地區檢測服務提供者的潛在收入成長，因為在這些地區，員工隱私保護優先於安全篩檢措施。

市場促進因素

全球非法藥物使用量的上升是藥物檢測市場的主要動力。不斷攀升的藥物濫用率迫使公共衛生機構加強篩檢工作，以追蹤成癮趨勢。這一激增也包括合成鴉片類藥物的氾濫，因此需要開發適應性強的毒理學檢測方法來檢測新型化合物。根據聯合國毒品犯罪防制署（UNODC）於2024年6月發布的《2024年世界毒品報告》，到2022年，全球吸毒者人數將達到2.92億，比過去十年成長20%。不斷擴大的吸毒者群體直接推動了康復計劃和法律調查所需的臨床檢測量。

此外，政府對職場藥物篩檢的嚴格規定也是主要促進因素，尤其是在安全至關重要的行業。在運輸和製造業等行業，監管機構正在執行嚴格的通訊協定以確保員工的適任性，並強制要求進行常規的入職前篩檢以避免法律責任。根據Quest Diagnostics於2024年5月發布的“藥物檢測指數”，2023年美國普通勞動者的吸食大麻檢測率上升了4.7%，迫使雇主維持嚴格的檢測標準。此外，執法資料庫也為市場提供了支援。美國聯邦汽車運輸安全管理局（FMCSA）報告稱，2024年約有16.4萬名商業駕駛人因違反毒品法規而被吊銷駕照，這凸顯了持續監控的重要性。

市場挑戰

關於隱私權和合法化大麻的複雜監管環境，對全球藥物檢測市場的成長構成了重大障礙。隨著各地推出法律保護非工作時間使用大麻並嚴格執行資料隱私保護，跨國公司面臨合規環境的碎片化。這種法律上的零碎化迫使企業放寬篩檢通訊協定，以避免訴訟和就業歧視指控。因此，許多雇主選擇將大麻排除在標準檢測項目之外，這直接降低了依賴綜合多項篩檢的檢測服務提供者的收入潛力。

此外，聯邦安全法規與州級合法化政策之間的不一致造成了嚴重的營運摩擦，尤其是在安全至關重要的行業。雇主必須在職業安全的重要性與勞動力萎縮和法律責任之間尋求平衡，這往往導致檢測頻率和範圍的降低。這種不願實施嚴格篩檢計畫的做法限制了市場規模，並阻礙了標準化全球政策的實施。 2024年，美國交通運輸研究所（ATRI）分析了聯邦數據，發現國家藥物資訊交換中心約60%的陽性檢測結果是由於違反大麻相關規定造成的，這凸顯了不斷發展的合法化趨勢與既定的職場安全要求之間存在的嚴重衝突。

市場趨勢

隨著雇主尋求防止檢體篡改並提高採集效率，口腔液檢測的快速普及正在迅速改變市場格局。該方法之所以日益流行，是因為它允許在不侵犯隱私的情況下進行檢體採集，從而直接應對日益嚴重的候選人身份欺詐和尿液檢查欺詐問題。此外，在安全關鍵型職業中，傳統方法容易被竄改，因此需要更嚴格的檢驗流程，這也進一步推動了這項轉變。根據HireRight於2025年6月發布的《2025年全球基準報告》，六分之一的受訪者表示在招募過程中遭遇過身分欺詐，這推動了對口腔液分析等防篡改解決方案的需求。

同時，隨著員工藥物使用模式的改變，包括標準五項檢測無法檢出的合成鴉片類藥物，多項藥物篩檢能力的廣泛應用變得日益重要。數據顯示，員工在通過初次篩檢後復吸率居高不下，促使各機構擴大檢測通訊協定，將Fentanyl等化合物納入其中。這種轉變在入職前檢測和在職檢測結果的差異上尤其明顯，因此有必要在隨機檢測項目中擴大監測範圍。 Quest Diagnostics 在 2025 年 9 月發布的《藥物檢測指數》中指出，隨機檢測中普通員工Fentanyl的陽性率比入職前篩檢高出 707%，凸顯了全面多項藥物檢測的迫切需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球藥物檢測市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（耗材、設備、快速檢測設備、服務）
    • 檢體類型（尿液檢體、口腔液檢體、毛髮檢體、其他）
    • 依藥物類型（酒精、大麻/毒品、古柯鹼、鴉片類藥物、安非他命和甲基安非他命、LSD、其他）
    • 依最終使用者（藥物檢測實驗室、職場、醫院等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美藥物檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲藥物檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區藥物檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲藥物檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲藥物檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球藥物檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott
  • Siemens
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • LabCorp
  • Roche
  • Hologic
  • Alere
  • Danaher Corporation
  • OraSure Technologies

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 26709

The Global Drug Testing Market is projected to expand from USD 15.56 Billion in 2025 to USD 21.26 Billion by 2031, registering a CAGR of 5.34%. This industry sector involves the technical analysis of biological specimens, such as urine, hair, oral fluid, and blood, to identify illicit substances or their metabolites. Key drivers supporting this growth include strict government regulations concerning workplace safety and the increasing global prevalence of substance abuse, which demands rigorous screening to minimize occupational risks. Data from the National Safety Council in 2024 indicates that 78% of surveyed employers are concerned about opioid use affecting their workplace, underscoring the critical need for effective screening programs to ensure operational safety and reduce liability.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 15.56 Billion
Market Size 2031USD 21.26 Billion
CAGR 2026-20315.34%
Fastest Growing SegmentUrine Samples
Largest MarketNorth America

However, market expansion faces a significant hurdle due to the complex regulatory landscape regarding privacy rights and the legalization of previously controlled substances, especially cannabis. Varying laws across different jurisdictions create substantial compliance burdens for multinational organizations, often compelling them to limit the scope of their testing protocols. This legal fragmentation hinders the implementation of standardized global testing policies, thereby restricting potential revenue growth for testing providers in specific regions where employee privacy protections supersede safety screening measures.

Market Driver

The rising global prevalence of illicit drug consumption acts as a primary catalyst for the drug testing market. As substance abuse rates increase, public health organizations are compelled to enhance screening initiatives to track addiction trends. This surge includes the spread of synthetic opioids, requiring adaptable toxicological analysis to detect emerging compounds. The United Nations Office on Drugs and Crime reported in its June 2024 'World Drug Report 2024' that the number of people using drugs globally reached 292 million in 2022, a 20 percent rise over the previous decade. This growing user base directly drives the volume of clinical tests needed for rehabilitation programs and legal investigations.

Additionally, the implementation of stringent government mandates for workplace drug screening serves as a major driver, particularly in safety-sensitive industries. Regulatory bodies enforce rigorous protocols to ensure employee fitness in sectors like transportation and manufacturing, necessitating routine pre-employment screening policies to mitigate liability. In May 2024, Quest Diagnostics' 'Drug Testing Index' noted a 4.7% increase in the marijuana positivity rate within the general United States workforce in 2023, forcing employers to maintain vigilant testing standards. The market is further supported by enforcement databases; the Federal Motor Carrier Safety Administration reported in 2024 that approximately 164,000 commercial drivers remained in prohibited status due to drug violations, highlighting the reliance on continuous monitoring.

Market Challenge

The intricate regulatory landscape regarding privacy rights and cannabis legalization presents a formidable barrier to the growth of the Global Drug Testing Market. As jurisdictions increasingly enact laws protecting off-duty cannabis use and enforcing strict data privacy, multinational corporations encounter a fragmented compliance environment. This legal patchwork forces organizations to dilute their screening protocols to avoid litigation and hiring discrimination claims. Consequently, many employers are choosing to exclude marijuana from standard testing panels, which directly reduces the revenue potential for testing providers dependent on comprehensive multi-panel screenings.

Furthermore, the misalignment between federal safety mandates and state-level legalization creates significant operational friction, particularly in safety-sensitive industries. Employers must balance the imperative of occupational safety against a shrinking labor pool and legal liability, often resulting in reduced testing frequency or scope. This hesitation to implement rigorous screening programs stifles market volume and complicates the adoption of standardized global policies. In 2024, the American Transportation Research Institute analyzed federal data and found that marijuana violations accounted for approximately 60% of all positive drug tests in the national clearinghouse, highlighting the severe conflict between evolving legalization trends and established workplace safety requirements.

Market Trends

The Accelerated Adoption of Oral Fluid Testing is rapidly reshaping the market as employers aim to mitigate specimen tampering and improve collection efficiency. This method is increasingly favored for enabling observed sample collection without violating privacy, thereby directly addressing the growing challenge of candidate identity fraud and cheating during urine screenings. The transition is further supported by the need for more robust verification processes in safety-sensitive roles where traditional methods may be vulnerable to subversion. According to HireRight's '2025 Global Benchmark Report' in June 2025, one in six respondents reported that their business experienced identity fraud during the hiring process, driving the demand for tamper-evident solutions like oral fluid analysis.

Simultaneously, the Proliferation of Multi-Panel Screening Capabilities is becoming critical as workforce drug use patterns evolve to include synthetic opioids not detected by standard five-panel tests. Organizations are expanding their testing protocols to include compounds such as fentanyl, driven by data revealing that employees often resume substance use after passing initial screenings. This shift is particularly evident in the disparity between pre-employment and active-duty test results, necessitating broader surveillance panels for random testing programs. Quest Diagnostics reported in the September 2025 '2025 Drug Testing Index' that the positivity rate for fentanyl in the general workforce was 707% higher in random drug tests compared to pre-employment screenings, highlighting the urgent operational requirement for comprehensive multi-panel diagnostics.

Key Market Players

  • Abbott
  • Siemens
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • LabCorp
  • Roche
  • Hologic
  • Alere
  • Danaher Corporation
  • OraSure Technologies

Report Scope

In this report, the Global Drug Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Testing Market, By Product

  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services

Drug Testing Market, By Sample

  • Urine Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other

Drug Testing Market, By Drug Type

  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD
  • Others

Drug Testing Market, By End User

  • Drug Testing Laboratories
  • Workplaces
  • Hospitals
  • Others

Drug Testing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Drug Testing Market.

Available Customizations:

Global Drug Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Drug Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Instruments, Rapid Testing Devices, Services)
    • 5.2.2. By Sample (Urine Samples, Oral Fluid Samples, Hair Samples, Other)
    • 5.2.3. By Drug Type (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Others)
    • 5.2.4. By End User (Drug Testing Laboratories, Workplaces, Hospitals, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Drug Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Sample
    • 6.2.3. By Drug Type
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Drug Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Sample
        • 6.3.1.2.3. By Drug Type
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Drug Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Sample
        • 6.3.2.2.3. By Drug Type
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Drug Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Sample
        • 6.3.3.2.3. By Drug Type
        • 6.3.3.2.4. By End User

7. Europe Drug Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Sample
    • 7.2.3. By Drug Type
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Drug Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Sample
        • 7.3.1.2.3. By Drug Type
        • 7.3.1.2.4. By End User
    • 7.3.2. France Drug Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Sample
        • 7.3.2.2.3. By Drug Type
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Drug Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Sample
        • 7.3.3.2.3. By Drug Type
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Drug Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Sample
        • 7.3.4.2.3. By Drug Type
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Drug Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Sample
        • 7.3.5.2.3. By Drug Type
        • 7.3.5.2.4. By End User

8. Asia Pacific Drug Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Sample
    • 8.2.3. By Drug Type
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Drug Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Sample
        • 8.3.1.2.3. By Drug Type
        • 8.3.1.2.4. By End User
    • 8.3.2. India Drug Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Sample
        • 8.3.2.2.3. By Drug Type
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Drug Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Sample
        • 8.3.3.2.3. By Drug Type
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Drug Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Sample
        • 8.3.4.2.3. By Drug Type
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Drug Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Sample
        • 8.3.5.2.3. By Drug Type
        • 8.3.5.2.4. By End User

9. Middle East & Africa Drug Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Sample
    • 9.2.3. By Drug Type
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Drug Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Sample
        • 9.3.1.2.3. By Drug Type
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Drug Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Sample
        • 9.3.2.2.3. By Drug Type
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Drug Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Sample
        • 9.3.3.2.3. By Drug Type
        • 9.3.3.2.4. By End User

10. South America Drug Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Sample
    • 10.2.3. By Drug Type
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Drug Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Sample
        • 10.3.1.2.3. By Drug Type
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Drug Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Sample
        • 10.3.2.2.3. By Drug Type
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Drug Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Sample
        • 10.3.3.2.3. By Drug Type
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Drug Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Siemens
  • 15.3. Thermo Fisher Scientific
  • 15.4. Quest Diagnostics
  • 15.5. LabCorp
  • 15.6. Roche
  • 15.7. Hologic
  • 15.8. Alere
  • 15.9. Danaher Corporation
  • 15.10. OraSure Technologies

16. Strategic Recommendations

17. About Us & Disclaimer